Writing An Effective 483 Response

5th Annual FDA and the Changing Paradigm for HCT/P Regulation University of Rhode Island and Pharma Conference Las Vegas, NV, January 2009 Anita Richardson Associate Director for Policy Office of Compliance & Biologics Quality

A well-reasoned, complete, and timely 483 response is in your best interest.

The 483 response

There is no regulatory requirement to respond to the 483….

…..however, it’s in your best interest to respond in writing.

Writing an effective 483 response Topics to be covered:

• Regulatory framework and FDA policies and procedures for the FDA 483;
• Four reasons for submitting a well-reasoned, complete, and timely 483 response;
• Eight suggestions for an effective 483 response.

Form FDA 483 Inspectional Observations

• Under what authority does FDA issue 483s?

– “The observations of objectionable conditions and practices listed on the front of this form are reported:

1) Pursuant to Section 704(b) of the FFD&C Act

2) To assist firms inspected in complying with the Acts and regulations enforced by the FDA”

Form FDA 483 Inspectional Observations

Clarification:

• What is a Form FDA 483?
• What is it not?

Form FDA 483 Inspectional Observations

• List of inspectional observations
• 483 language

“This document lists observations made bythe FDA representative during the inspectionof your facility. They are inspectionalobservations, and do not represent a finalAgency determination regarding yourcompliance.”

(Form FDA 483 & FDA Investigations Operations Manual (IOM) 5.2.3.1.4 http://www.fda.gov/ora/inspect_ref/iom/)

FDA’s expectations during an inspection

• “…investigators should make every reasonable effort to discuss all observations with management… as they are observed, or on a daily basis to minimize surprises, errors, and misunderstandings when an FDA 483 is issued.”
• IOM 5.2.3

FDA’s expectations during an inspection (2)

• “Industry may use this opportunity to ask questions about the observations, request clarification, and inform the inspection team what corrections have been or will be made…”
• IOM 5.2.3

FDA activities following the inspection

• Investigators prepare the Establishment Inspection Report (EIR) & recommend classification of the inspection
• Supervisory review
• Classification of inspection: NAI, VAI, OAI
• If OAI, referral to district’s Compliance Branch for further review & action

Why submit a 483 response?

Four reasons for submitting a well-reasoned, complete, and timely 483 response

1. Could possibly mitigate an FDA compliance decision for further action,

e.g. untitled letter, Warning Letter

Four reasons for submitting a well-reasoned, complete, and timely 483 response

1. (cont)

• “As a general rule, a Warning Letter should not be issued if the agency concludes that a firm’s corrective actions are adequate and that the violations that would have supported the letter have been corrected.”
• Regulatory Procedures Manual, http://www.fda.gov/ora/compliance_ref/rpm/pdf/ch4.pdf

Four reasons for submitting a well-reasoned, complete, and timely 483 response

2. Demonstrates to the FDA (and other stakeholders) an understanding and acknowledgement of the observations

Four reasons for submitting a well-reasoned, complete, and timely 483 response

3. Demonstrates to the FDA (and other stakeholders) a commitment to correct, i.e. the intent to voluntarily comply

Four reasons for submitting a well-reasoned, complete, and timely 483 response

4. Establishes credibility with FDA

Suggestions for addressing 483 observations

Following an Inspection – Suggestions:

• Assess each observation

• Focus on specifics
• Focus on system-wide implications
• Focus on global implications
• Consider affected products
• Consider root-cause analysis
• Focus on the regulatory requirement(s) associated with the observation

Develop action plan to achieve immediate, short-term, and long-term correction and to prevent recurrence

• Know when to seek outside assistance
• Following an Inspection – Suggestions (cont):

Eight suggestions for an effective 483 response

Eight suggestions for an effective 483 response:

1)Include a commitment/statement from senior leadership

2)Address each observation separately

3)Note whether you agree or disagree with the observation

Eight suggestions for an effective 483 response:

4. Provide corrective action accomplished and/or planned; tell FDA the plan

• Be specific (e.g. observation-by-observation)
• Be complete
• Be realistic
• Be able to deliver what you promise
• Address affected products

Eight suggestions for an effective 483 response:

1) Provide time frames for correction

2) Provide method of verification and/ormonitoring for corrections

3) Consider submitting documentation ofcorrections where reasonable & feasible

4) BE TIMELY

To summarize

• There is no regulatory requirement to respond to the 483….

…..however, a well-reasoned, complete, and timely 483 response is in your best interest.

Contacts For CBER Assistance:

WWW.FDA.GOV/CBER

• Email CBER:

• Manufacturers: matt@cber.fda.gov
• Consumers, health care: octma@cber.fda.gov

• Phone:

• +1-301-827-1800

“The safest way to double your money is to fold it over once and put it in your pocket”

Kin Hubbard